Presentation TCT 2016 Follow-up Evaluation After LAA Closure Presenter: David R. Holmes Jr., Jacqueline Saw, Bushra S Rana November 01, 2016
Presentation TCT 2016 Iatrogenic ASD After Transeptal Interventions: Frequency, Impact, and Treatment (If Any) Presenter: Lee N. Benson, Ziyad M. Hijazi, David R. Holmes Jr. November 01, 2016
News Conference News TCT 2016 Final RESPECT Data Support PFO Closure for Cryptogenic Stroke Prevention Yael L. Maxwell November 01, 2016
News Conference News TCT 2016 Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint Shelley Wood November 01, 2016
Presentation TCT 2016 TCT 1524: Simultaneous Transfemoral Aortic and Transseptal Mitral Valves Replacement Utilizing Sapien 3 Valves in Native Aortic and Mitral Valves Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Firas Zahr October 31, 2016
Presentation TCT 2016 TCT 1520: Percutaneous Closure of Aortic Pseudo Aneurysm in a Young Female With Atrial Septal Occluder Presenter: David R. Holmes Jr., Clifford J. Kavinsky, shantanu Deshpande October 31, 2016
Presentation TCT 2016 TCT 1492: Double Valve Case TAVR and TMVR in Native Annulus at the Same Time Presenter: David R. Holmes Jr., Clifford J. Kavinsky, M. Rizwan Sardar October 31, 2016
Presentation TCT 2016 TCT 1631: Percutaneous Treatment of Multiple LAD-RV Fistula in Heart Transplant Recipient Presenter: David R. Holmes Jr., Clifford J. Kavinsky, Farzin Beygui October 31, 2016
Presentation TCT 2016 Strengths and Limitations of Post-Approval Registries as Vehicles to Track Safety and Inform Device Label Expansion Presenter: Owen Faris, Mitchell W. Krucoff, David R. Holmes Jr. October 31, 2016
News Conference News TCT 2016 EXCEL y NOBLE: Los Resultados Contrarios Plantean un Dilema a la Hora de Elegir entre PCI y CABG en el Manejo de la Enfermedad de Tronco Coronario Izdo. Michael O'Riordan October 31, 2016
News Conference News TCT 2016 EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease Michael O'Riordan October 31, 2016
Presentation TCT 2016 Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes! Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Brian K. Whisenant October 30, 2016
Presentation TCT 2016 Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? No A Combination of Antiplatelet Agents and Warfarin/NOACs Shoud Be Tried First! Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Freek W.A. Verheugt October 30, 2016
Presentation TCT 2016 Debate #1: Should Low bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? Yes As Long As Full Consent Is Provided, Let the Patient Decide! Presenter: David R. Holmes Jr., Josep Rodés-Cabau, David Hildick-Smith October 30, 2016
Presentation TCT 2016 Debate #1: Should Low Bleeding Risk Patients With Atrial Fibrillation Be Offered LAA Closure? No Chronic Anticoagulation Should be Offered First Presenter: David R. Holmes Jr., Josep Rodés-Cabau, Stefan C. Bertog October 30, 2016
Presentation TCT 2016 Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven? Presenter: Vivek Y. Reddy, Steven J. Yakubov, David R. Holmes Jr. October 30, 2016
News Daily News Hybrid Algorithm for CTO PCI Delivers High Success Rates, Registry Affirms Todd Neale October 28, 2016
News Daily News Un Informe Ofrece una Visión de la Experiencia Comercial Inicial de la TAVR Todd Neale November 30, 2015